247 related articles for article (PubMed ID: 23685946)
1. Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy.
Foy MC; Estrella MM; Lucas GM; Tahir F; Fine DM; Moore RD; Atta MG
Clin J Am Soc Nephrol; 2013 Sep; 8(9):1524-32. PubMed ID: 23685946
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and outcomes of HIV-associated immune complex kidney disease.
Booth JW; Hamzah L; Jose S; Horsfield C; O'Donnell P; McAdoo S; Kumar EA; Turner-Stokes T; Khatib N; Das P; Naftalin C; Mackie N; Kingdon E; Williams D; Hendry BM; Sabin C; Jones R; Levy J; Hilton R; Connolly J; Post FA;
Nephrol Dial Transplant; 2016 Dec; 31(12):2099-2107. PubMed ID: 26786550
[TBL] [Abstract][Full Text] [Related]
3. Glomerular diseases related to HIV in Colombian population: Better outcomes with highly active antiretroviral therapy?
Muñoz-Velandia O; García-Peña Á; Garzón-Herazo J; Contreras-Villamizar K; Rodríguez-Sánchez M; Garcia-Consuegra E; Toro-Trujillo E
J Infect Dev Ctries; 2020 Sep; 14(9):1027-1032. PubMed ID: 33031092
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy and treatment options for HIV-associated nephropathy.
Menez S; Hanouneh M; McMahon BA; Fine DM; Atta MG
Expert Opin Pharmacother; 2018 Jan; 19(1):39-48. PubMed ID: 29224373
[TBL] [Abstract][Full Text] [Related]
5. Impact of Antiretroviral Therapy on Kidney Disease in HIV Infected Individuals - A Qualitative Systematic Review.
Adnani H; Agrawal N; Khatri A; Vialet J; Zhang M; Cervia J
J Int Assoc Provid AIDS Care; 2022; 21():23259582221089194. PubMed ID: 35369795
[TBL] [Abstract][Full Text] [Related]
6. Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition.
Wei A; Burns GC; Williams BA; Mohammed NB; Visintainer P; Sivak SL
Kidney Int; 2003 Oct; 64(4):1462-71. PubMed ID: 12969167
[TBL] [Abstract][Full Text] [Related]
7. HIV-related nephropathy: a South African perspective.
Gerntholtz TE; Goetsch SJ; Katz I
Kidney Int; 2006 May; 69(10):1885-91. PubMed ID: 16625149
[TBL] [Abstract][Full Text] [Related]
8. HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study.
Abbott KC; Trespalacios FC; Agodoa LY; Ahuja TS
BMC Nephrol; 2003 Jul; 4():5. PubMed ID: 12837135
[TBL] [Abstract][Full Text] [Related]
9. HIV-associated nephropathy: case study and review of the literature.
Ross MJ; Klotman PE; Winston JA
AIDS Patient Care STDS; 2000 Dec; 14(12):637-45. PubMed ID: 11119430
[TBL] [Abstract][Full Text] [Related]
10. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.
Szczech LA; Gupta SK; Habash R; Guasch A; Kalayjian R; Appel R; Fields TA; Svetkey LP; Flanagan KH; Klotman PE; Winston JA
Kidney Int; 2004 Sep; 66(3):1145-52. PubMed ID: 15327410
[TBL] [Abstract][Full Text] [Related]
11. The clinical characteristics and antiretroviral dosing patterns of HIV-infected patients receiving dialysis.
Szczech LA; Kalayjian R; Rodriguez R; Gupta S; Coladonato J; Winston J;
Kidney Int; 2003 Jun; 63(6):2295-301. PubMed ID: 12753321
[TBL] [Abstract][Full Text] [Related]
12. Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy.
Razzak Chaudhary S; Workeneh BT; Montez-Rath ME; Zolopa AR; Klotman PE; Winkelmayer WC
Nephrol Dial Transplant; 2015 Oct; 30(10):1734-40. PubMed ID: 26175146
[TBL] [Abstract][Full Text] [Related]
13. The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations.
Wearne N; Swanepoel CR; Boulle A; Duffield MS; Rayner BL
Nephrol Dial Transplant; 2012 Nov; 27(11):4109-18. PubMed ID: 22200584
[TBL] [Abstract][Full Text] [Related]
14. Association of HIV Suppression With Kidney Disease Progression Among HIV-Positive African Americans With Biopsy-Proven Classic FSGS.
McMahon BA; Hanouneh M; Chedid A; Fine DM; Chen TK; Foy M; Lucas GM; Estrella MM; Atta MG
J Acquir Immune Defic Syndr; 2018 Dec; 79(5):639-643. PubMed ID: 30204721
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors.
Jotwani V; Li Y; Grunfeld C; Choi AI; Shlipak MG
Am J Kidney Dis; 2012 May; 59(5):628-35. PubMed ID: 22206742
[TBL] [Abstract][Full Text] [Related]
16. Chronic kidney disease associated with perinatal HIV infection in children and adolescents.
Purswani MU; Chernoff MC; Mitchell CD; Seage GR; Zilleruelo G; Abitbol C; Andiman WA; Kaiser KA; Spiegel H; Oleske JM;
Pediatr Nephrol; 2012 Jun; 27(6):981-9. PubMed ID: 22366874
[TBL] [Abstract][Full Text] [Related]
17. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection.
Winston JA; Klotman ME; Klotman PE
Kidney Int; 1999 Mar; 55(3):1036-40. PubMed ID: 10027941
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era.
Abbott KC; Hypolite I; Welch PG; Agodoa LY
J Nephrol; 2001; 14(5):377-83. PubMed ID: 11730270
[TBL] [Abstract][Full Text] [Related]
19. The impact of HIV on chronic kidney disease outcomes.
Choi AI; Rodriguez RA; Bacchetti P; Bertenthal D; Volberding PA; O'Hare AM
Kidney Int; 2007 Dec; 72(11):1380-7. PubMed ID: 17805235
[TBL] [Abstract][Full Text] [Related]
20. Presentation of HIV-associated nephropathy and outcome in HAART-treated patients.
Bigé N; Lanternier F; Viard JP; Kamgang P; Daugas E; Elie C; Jidar K; Walker-Combrouze F; Peraldi MN; Isnard-Bagnis C; Servais A; Lortholary O; Noël LH; Bollée G
Nephrol Dial Transplant; 2012 Mar; 27(3):1114-21. PubMed ID: 21745806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
